TMPRSS2 and COVID-19: The clinical relevance is reinforced by findings indicating that symptomatic COVID-19 patients exhibit higher TMPRSS2 expression levels than asymptomatic individuals, suggesting that targeting this protease could be particularly beneficial in treatment strategies aimed at symptomatic patients.